US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist
  • 317.050
  • -1.960-0.61%
Close Jul 2 16:00 ET
14.07BMarket Cap15.01P/E (TTM)

United Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
33.70%677.7M
20.20%2.33B
25.07%614.7M
18.10%609.4M
27.76%596.5M
9.74%506.9M
14.88%1.94B
18.38%491.5M
16.03%516M
4.57%466.9M
Operating revenue
33.70%677.7M
20.20%2.33B
25.07%614.7M
18.10%609.4M
27.76%596.5M
9.74%506.9M
14.88%1.94B
18.38%491.5M
16.03%516M
4.57%466.9M
Cost of revenue
39.39%72.9M
69.85%257.5M
20.75%71M
88.44%70.1M
115.82%64.1M
101.93%52.3M
23.76%151.6M
69.94%58.8M
34.30%37.2M
-20.16%29.7M
Gross profit
33.04%604.8M
15.99%2.07B
25.65%543.7M
12.64%539.3M
21.77%532.4M
4.27%454.6M
14.18%1.78B
13.69%432.7M
14.82%478.8M
6.82%437.2M
Operating expense
46.00%248.5M
9.95%885.1M
10.31%283.6M
29.06%212.3M
-6.97%219M
15.00%170.2M
-20.07%805M
21.96%257.1M
-12.64%164.5M
25.82%235.4M
Selling and administrative expenses
65.41%144.4M
-1.04%477.1M
-19.00%132.2M
29.67%127.6M
-8.13%130M
10.51%87.3M
3.23%482.1M
27.60%163.2M
-9.81%98.4M
25.44%141.5M
-Selling and marketing expense
37.28%23.2M
15.54%81.8M
4.78%24.1M
20.35%20.7M
24.84%20.1M
16.55%16.9M
9.94%70.8M
40.24%23M
0.00%17.2M
-5.85%16.1M
-General and administrative expense
72.16%121.2M
-3.89%395.3M
-22.90%108.1M
31.65%106.9M
-12.36%109.9M
9.15%70.4M
2.16%411.3M
25.74%140.2M
-11.64%81.2M
31.03%125.4M
Research and development costs
25.57%104.1M
26.35%408M
61.24%151.4M
28.14%84.7M
-5.22%89M
20.14%82.9M
-40.21%322.9M
13.27%93.9M
-16.54%66.1M
26.38%93.9M
Operating profit
25.28%356.3M
20.95%1.18B
48.12%260.1M
4.04%327M
55.30%313.4M
-1.25%284.4M
76.24%979.7M
3.42%175.6M
37.43%314.3M
-9.18%201.8M
Net non-operating interest income expense
162.99%40.5M
707.81%103.4M
322.35%35.9M
624.39%29.7M
3,633.33%22.4M
3,950.00%15.4M
773.68%12.8M
1,800.00%8.5M
612.50%4.1M
185.71%600K
Non-operating interest income
84.25%53.8M
259.96%162.7M
145.19%51M
240.60%45.3M
447.06%37.2M
579.07%29.2M
170.66%45.2M
395.24%20.8M
250.00%13.3M
70.00%6.8M
Non-operating interest expense
-3.62%13.3M
83.02%59.3M
22.76%15.1M
69.57%15.6M
138.71%14.8M
193.62%13.8M
74.19%32.4M
161.70%12.3M
100.00%9.2M
31.91%6.2M
Other net income (expense)
122.78%1.8M
66.59%-14M
88.68%-600K
16.95%-4.9M
98.84%-600K
-137.44%-7.9M
-205.01%-41.9M
81.60%-5.3M
74.89%-5.9M
-936.00%-51.8M
Special income (charges)
----
--0
--0
--0
--0
----
26.09%-1.7M
--0
--0
--0
-Write off
----
--0
--0
--0
--0
----
-26.09%1.7M
--0
--0
--0
Other non- operating income (expenses)
122.78%1.8M
65.17%-14M
88.68%-600K
16.95%-4.9M
98.84%-600K
-134.65%-7.9M
-195.26%-40.2M
81.60%-5.3M
74.89%-5.9M
-1,818.52%-51.8M
Income before tax
36.55%398.6M
34.05%1.27B
65.21%295.4M
12.58%351.8M
122.58%335.2M
-5.44%291.9M
60.06%950.6M
27.26%178.8M
52.89%312.5M
-30.44%150.6M
Income tax
80.39%92M
29.65%289.5M
67.67%78.3M
15.03%84.2M
119.65%76M
-25.87%51M
89.08%223.3M
65.02%46.7M
75.54%73.2M
-21.18%34.6M
Net income
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
47.08%239.3M
-32.79%116M
Net income continuous Operations
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
47.08%239.3M
-32.79%116M
Minority interest income
Net income attributable to the parent company
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
47.08%239.3M
-32.79%116M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
47.08%239.3M
-32.79%116M
Basic earnings per share
25.38%6.52
31.66%21.04
60.42%4.62
8.56%5.71
116.02%5.53
-2.07%5.2
50.75%15.98
15.66%2.88
45.30%5.26
-33.51%2.56
Diluted earnings per share
26.95%6.17
32.07%19.81
63.30%4.36
9.57%5.38
117.43%5.24
-3.38%4.86
49.11%15
13.62%2.67
43.57%4.91
-33.97%2.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 33.70%677.7M20.20%2.33B25.07%614.7M18.10%609.4M27.76%596.5M9.74%506.9M14.88%1.94B18.38%491.5M16.03%516M4.57%466.9M
Operating revenue 33.70%677.7M20.20%2.33B25.07%614.7M18.10%609.4M27.76%596.5M9.74%506.9M14.88%1.94B18.38%491.5M16.03%516M4.57%466.9M
Cost of revenue 39.39%72.9M69.85%257.5M20.75%71M88.44%70.1M115.82%64.1M101.93%52.3M23.76%151.6M69.94%58.8M34.30%37.2M-20.16%29.7M
Gross profit 33.04%604.8M15.99%2.07B25.65%543.7M12.64%539.3M21.77%532.4M4.27%454.6M14.18%1.78B13.69%432.7M14.82%478.8M6.82%437.2M
Operating expense 46.00%248.5M9.95%885.1M10.31%283.6M29.06%212.3M-6.97%219M15.00%170.2M-20.07%805M21.96%257.1M-12.64%164.5M25.82%235.4M
Selling and administrative expenses 65.41%144.4M-1.04%477.1M-19.00%132.2M29.67%127.6M-8.13%130M10.51%87.3M3.23%482.1M27.60%163.2M-9.81%98.4M25.44%141.5M
-Selling and marketing expense 37.28%23.2M15.54%81.8M4.78%24.1M20.35%20.7M24.84%20.1M16.55%16.9M9.94%70.8M40.24%23M0.00%17.2M-5.85%16.1M
-General and administrative expense 72.16%121.2M-3.89%395.3M-22.90%108.1M31.65%106.9M-12.36%109.9M9.15%70.4M2.16%411.3M25.74%140.2M-11.64%81.2M31.03%125.4M
Research and development costs 25.57%104.1M26.35%408M61.24%151.4M28.14%84.7M-5.22%89M20.14%82.9M-40.21%322.9M13.27%93.9M-16.54%66.1M26.38%93.9M
Operating profit 25.28%356.3M20.95%1.18B48.12%260.1M4.04%327M55.30%313.4M-1.25%284.4M76.24%979.7M3.42%175.6M37.43%314.3M-9.18%201.8M
Net non-operating interest income expense 162.99%40.5M707.81%103.4M322.35%35.9M624.39%29.7M3,633.33%22.4M3,950.00%15.4M773.68%12.8M1,800.00%8.5M612.50%4.1M185.71%600K
Non-operating interest income 84.25%53.8M259.96%162.7M145.19%51M240.60%45.3M447.06%37.2M579.07%29.2M170.66%45.2M395.24%20.8M250.00%13.3M70.00%6.8M
Non-operating interest expense -3.62%13.3M83.02%59.3M22.76%15.1M69.57%15.6M138.71%14.8M193.62%13.8M74.19%32.4M161.70%12.3M100.00%9.2M31.91%6.2M
Other net income (expense) 122.78%1.8M66.59%-14M88.68%-600K16.95%-4.9M98.84%-600K-137.44%-7.9M-205.01%-41.9M81.60%-5.3M74.89%-5.9M-936.00%-51.8M
Special income (charges) ------0--0--0--0----26.09%-1.7M--0--0--0
-Write off ------0--0--0--0-----26.09%1.7M--0--0--0
Other non- operating income (expenses) 122.78%1.8M65.17%-14M88.68%-600K16.95%-4.9M98.84%-600K-134.65%-7.9M-195.26%-40.2M81.60%-5.3M74.89%-5.9M-1,818.52%-51.8M
Income before tax 36.55%398.6M34.05%1.27B65.21%295.4M12.58%351.8M122.58%335.2M-5.44%291.9M60.06%950.6M27.26%178.8M52.89%312.5M-30.44%150.6M
Income tax 80.39%92M29.65%289.5M67.67%78.3M15.03%84.2M119.65%76M-25.87%51M89.08%223.3M65.02%46.7M75.54%73.2M-21.18%34.6M
Net income 27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M47.08%239.3M-32.79%116M
Net income continuous Operations 27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M47.08%239.3M-32.79%116M
Minority interest income
Net income attributable to the parent company 27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M47.08%239.3M-32.79%116M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M47.08%239.3M-32.79%116M
Basic earnings per share 25.38%6.5231.66%21.0460.42%4.628.56%5.71116.02%5.53-2.07%5.250.75%15.9815.66%2.8845.30%5.26-33.51%2.56
Diluted earnings per share 26.95%6.1732.07%19.8163.30%4.369.57%5.38117.43%5.24-3.38%4.8649.11%1513.62%2.6743.57%4.91-33.97%2.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg